Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Take LSD, stay out of prison? Huge study links psychedelic use to reduced recidivism

by Eric W. Dolan
January 8, 2014
in Psychopharmacology
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Psilocybe mushroomsA study of more than 25,000 people under community corrections supervision suggests the use of psychedelic drugs like LSD can keep people out of prison.

The research is the first in 40 years to examine whether drugs like LSD and “magic” mushrooms can help reform criminals.

“Our results provide a notable exception to the robust positive link between substance use and criminal behavior,” the researchers from the University of Alabama at Birmingham and Johns Hopkins University School of Medicine wrote in their study, which was published in the January issue of the Journal of Psychopharmacology.

“They add to both the older and emerging body of data indicating beneficial effects of hallucinogen interventions, and run counter to the legal classification as well as popular perception of hallucinogens as categorically harmful substances with no therapeutic potential.”

Psychedelic substances piqued the interest of researchers beginning in the 1950s. Studies indicated that the drugs could be combined with psychotherapy to treat a number of conditions, including alcoholism and drug addiction.

But scientific investigations into the therapeutic potential of LSD, psilocybin, mescaline, and other psychedelic drugs ground to a halt in the 1970s, when they were outlawed by the federal Controlled Substances Act.

“Offenders may be especially likely to benefit from hallucinogen treatment because involvement in the criminal justice system often results from drug-seeking behavior and impulsive conduct exacerbated by compulsive substance use,” the researchers explained in the study.

From 2002 to 2007, the researchers collected data on 25,622 individuals under community corrections supervision in Treatment Accountability for Safer Communities (TASC), a program for individuals with a history of drug abuse.

Only about 1 percent of those in the program were diagnosed with a hallucinogen use disorder. Cannabis use disorders, cocaine use disorders, and alcohol use disorders were the most common diagnoses in the group.

The researchers found those diagnosed with a hallucinogen use disorder were less likely to fail the TASC program compared to those without a hallucinogen use disorder. That means those with a hallucinogen use disorder were less likely to violate TASC rules or other legal requirements, less likely to fail to appear in court, and less likely to be incarcerated.

The study controlled for a large number of potentially confounding factors, including race, employment, marital status, age, criminal history, drug abuse history, gender, educational attainment, and more.

“The current findings should not at all be interpreted as advocating for recreational hallucinogen use. Nevertheless, they demonstrate that, in a real-world, substance-related intervention setting, hallucinogen use is associated with a lower probability of poor outcome,” the researchers wrote.

“We believe this calls for the continued scientific investigation of this unique class of substances.”

The study was authored by Peter S. Hendricks, C. Brendan Clark, Matthew W. Johnson, Kevin R. Fontaine, and Karen L. Cropsey.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Little-known psychedelic found to have a fascinating effect on cognitive flexibility after just a single dose
Psychedelic Drugs

Fascinating new advances in psychedelic science reveal how they may heal the mind

July 9, 2025

A series of recent studies has begun to map the specific neural, cognitive, and emotional processes that psychedelics influence—often in ways that challenge long-held assumptions

Read moreDetails
Ketamine repairs reward circuitry to reverse stress-induced anhedonia
Depression

Ketamine repairs reward circuitry to reverse stress-induced anhedonia

July 9, 2025

New research shows a single low, non-anesthetic dose of ketamine revived pleasure seeking in chronically stressed mice by restoring weakened excitatory synapses onto nucleus accumbens dopamine D1 neurons, pinpointing a circuit mechanism for the drug’s rapid antidepressant effect.

Read moreDetails
Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Stimulant medication improves working memory of children with ADHD, study finds
ADHD

New study exposes gap between ADHD drug use and safety research in children

June 30, 2025

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, highlighting a gap in long-term evidence.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Can sunshine make you happier? A massive study offers a surprising answer

New study links why people use pornography to day-to-day couple behavior

Virtual reality meditation eases caregiver anxiety during pediatric hospital stays, with stronger benefits for Spanish speakers

Fascinating new advances in psychedelic science reveal how they may heal the mind

Dysfunction within the sensory processing cortex of the brain is associated with insomnia, study finds

Prenatal exposure to “forever chemicals” linked to autistic traits in children, study finds

Ketamine repairs reward circuitry to reverse stress-induced anhedonia

Neuroscientists decode how people juggle multiple items in working memory

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy